The effect of motivational interviewing on self-efficacy in managing health and quality of life in pregnant women with gestational diabetes mellitus: a randomized controlled trial Authors: Fatma Yılmaz Fındık, Meltem Akbas Published: 2026 ABSTRACT BackgroundGestational diabetes mellitus is a multidimensional health problem that may negatively affect lifestyle behaviors and quality of life during pregnancy. Effective management of gestational diabetes mellitus requires self-efficacy in areas such as glycemic monitoring, healthy nutrition, physical activity, and weight control. Motivational interviewing is a patient-centered counseling approach that may support behavior change and health management. This study aimed to determine the effect of motivational interviewing on self-efficacy for health practices and quality of life in pregnant women diagnosed with gestational diabetes mellitus.MethodsThe study was conducted as a randomized controlled experimental trial. The study data were collected between June 1, 2024, and June 30, 2025, at two hospitals providing services in a city center in southern Türkiye. Participants were randomized into the intervention (n = 30) and control (n = 30) groups. While the pregnant women in the intervention group received four sessions of motivational interviewing, the control group received routine care. A Personal Information Form, the Self-Rated Abilities for Health Practices Scale, and the Short Form-36 Health Survey were used for data collection. To evaluate the effect of motivational interviewing, the changes in the groups over time were compared. The statistical significance level was accepted as p < 0.05.ResultsBefore the intervention, no significant difference was found between the groups in terms of descriptive characteristics or the mean scores of the Self-Rated Abilities for Health Practices Scale and the Short Form-36 Health Survey (p > 0.05). Following motivational interviewing, the intervention group demonstrated significantly higher total Self-Rated Abilities for Health Practices Scale scores than the control group at post-test (92.30 ± 5.33 vs. 72.46 ± 17.95, p < 0.001) and follow-up (93.13 ± 6.21 vs. 71.06 ± 17.21, p < 0.001). The intervention group also had significantly higher scores in the physical functioning (60.16 ± 9.51 vs. 45.33 ± 15.47), vitality (60.50 ± 8.23 vs. 46.33 ± 15.13), mental health (70.53 ± 7.08 vs. 60.66 ± 10.40), social functioning (68.33 ± 15.99 vs. 56.48 ± 19.67), and general health perception (64.66 ± 7.87 vs. 47.32 ± 11.65) domains of the Short Form-36 Health Survey at post-test, with the differences between groups reaching statistical significance (p < 0.05).ConclusionThis study demonstrates that motivational interviewing is effective in increasing self-efficacy and quality of life in pregnant women diagnosed with gestational diabetes mellitus. Integrating motivational interviewing into care processes is recommended as an effective approach that can contribute to supporting self-efficacy and quality of life in these pregnant women.Trial registrationThe study was registered at ClinicalTrials.gov (ID: NCT06243939). First Submitted Date: 15.11.2023.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12884-026-09538-8. Introduction Pregnancy is a physiological process; however, it may involve various risks for both the mother and the fetus [1]. Gestational Diabetes Mellitus (GDM) is one of the most common metabolic disorders in pregnancy and is defined as glucose intolerance first recognized during pregnancy [2–4]. The global prevalence of GDM ranges between 1 and 28%, with a reported incidence of approximately 7.7% in Türkiye [5, 6]. GDM is associated with adverse maternal outcomes such as preeclampsia, cesarean birth, and long-term development of type 2 diabetes mellitus, as well as fetal and neonatal complications including macrosomia, hypoglycaemia, and birth trauma. Nevertheless, effective management of GDM can substantially reduce these complications [2]. The management of GDM primarily relies on lifestyle modifications, including blood glucose monitoring, medical nutrition therapy, and regular physical activity [7, 8]. It has been reported that 70–85% of pregnant women with GDM can be effectively managed through lifestyle modifications alone [8]. In this process, midwives play a crucial role in supporting self-care behaviours and promoting sustainable behavioural change [9]. Sustaining lifestyle modifications is closely associated with health management self-efficacy. Self-efficacy refers to an individual’s belief in their ability to successfully perform a specific behaviour and has been shown to positively influence disease management and quality of life [10]. Among women diagnosed with GDM, higher self-efficacy levels have been positively associated with healthy eating and physical activity behaviours [11]. Beyond its physical consequences, GDM also negatively affects psychosocial well-being and quality of life. Studies indicate that women with GDM report lower quality of life compared to healthy pregnant women [12–15]. Therefore, structured interventions that support self-management and positive health behaviours are needed in this population [16]. Motivational Interviewing (MI) is a client-centered counseling approach designed to strengthen intrinsic motivation for behavioral change [17–19]. Initially developed for addiction treatment, MI has increasingly been used in the management of chronic diseases such as diabetes mellitus [20]. Limited evidence suggests that MI may positively influence physical activity and weight management among women with GDM [21–23]. However, GDM is a multidimensional condition that affects self-management skills, psychosocial adaptation, and quality of life [24, 25]. To date, no study has comprehensively evaluated the effects of MI on both health management self-efficacy and quality of life in women with GDM from a midwifery and nursing care perspective. This gap highlights the need for evidence-based interventions that can be integrated into routine maternity care. Accordingly, this study aimed to evaluate the effects of motivational interviewing on health management self-efficacy and quality of life among pregnant women diagnosed with gestational diabetes mellitus. Study HypothesesH1: MI increases health management self-efficacy in pregnant women diagnosed with GDM.H2: MI improves the quality of life in pregnant women diagnosed with GDM. H1: MI increases health management self-efficacy in pregnant women diagnosed with GDM. H1: MI increases health management self-efficacy in pregnant women diagnosed with GDM. H2: MI improves the quality of life in pregnant women diagnosed with GDM. H2: MI improves the quality of life in pregnant women diagnosed with GDM. Methods Health management self-efficacy was identified as the primary outcome based on its central relevance to the study objective and intervention framework. Quality of life was considered a secondary outcome reflecting an important but complementary aspect of maternal well-being. Type of research The present study employed a randomized controlled experimental design with a 1:1 allocation ratio in a parallel-group framework. All procedural steps and reporting were conducted in strict adherence to the CONSORT (Consolidated Standards of Reporting Trials) guidelines to ensure methodological rigor. Furthermore, the trial was registered at ClinicalTrials.gov with the identifier NCT06243939. First Submitted Date: 15.11.2023 (Fig. 1).Fig. 1CONSORT (2025) Flow Diagram [34] CONSORT (2025) Flow Diagram [34] Place and time of the research The study was conducted with pregnant women diagnosed with GDM who applied to the polyclinic units of two public hospitals in southern Türkiye between June 1, 2024, and June 30, 2025. Participants and eligibility criteria Women who voluntarily agreed to participate; were diagnosed with GDM for the first time; were between 22–28 weeks of gestation; were aged 19 years or older; were able to speak and understand Turkish; had a singleton viable pregnancy; owned and were able to use a mobile phone; and attended regular antenatal follow-ups at the same hospital throughout pregnancy were included in the study. Women with pregestational diabetes (type 1 or type 2), a psychiatric diagnosis, a chronic disease, obstetric risk factors such as threatened preterm labour, placenta previa, or premature rupture of membranes, any communication barrier (e.g., hearing impairment), or use of a language other than Turkish were excluded. Additionally, women who no longer wished to continue participation, delivered before 37 weeks of gestation, developed any chronic disease during the study, or could not be contacted were withdrawn from the study. Universe and sample of the research The sample size was calculated using G*Power version 3.1.9.7. Based on repeated measures analysis of variance, with two groups, three measurement time points, an effect size of 0.25, a 5% margin of error, and 90% power, it was determined that at least 30 pregnant women per group (total N = 60) were required. Considering possible attrition, the sample size was increased by 10%, and 33 participants were recruited for each group. Initially, a total of 66 pregnant women (33 in the intervention group and 33 in the control group) were included. During the intervention process, three women from the intervention group (one due to relocation and two due to loss of contact) and three women from the control group (one lost to follow-up, one who developed hypertension, and one who experienced preterm birth) were excluded. Therefore, analyses were conducted using a per-protocol approach based on 30 participants in the intervention group and 30 in the control group who completed all measurements. Since missing data were associated with withdrawal before completing the intervention and follow-up process and were considered potentially non-random, the per-protocol analysis approach was deemed methodologically appropriate. The equal and low attrition in both groups preserved sample balance and did not adversely affect internal validity. According to post hoc power analysis conducted at the end of the study, based on the total score of the Self Rated Abilities for Health Practices Scale (SRAHPS) and the physical functioning subscale of the Short Form-36 Health Survey(SF-36), the statistical power of the study was 0.99 (1-β = 0.99). Since the SF-36 does not provide a total score, a subscale was randomly selected for post hoc power analysis, and the analysis was performed using the physical functioning subscale. Randomization Assignment of pregnant women to the intervention and control groups was performed using randomization. The Random Integer Generator available at random.org was used for this purpose [26]. Random numbers between 1 and 66 were generated through the system, and by drawing lots, “1” was designated to represent the intervention group and “2” the control group. Eligible participants were assigned to these numbers according to their order of admission to the outpatient clinic. Blinding and bias Blind techniques were applied during data entry, statistical analysis, and reporting procedures to minimize potential bias. Before data collection began, the researcher contacted the statistician who performed the randomization and obtained the allocation list, after which the intervention was initiated. Data entry into the computer was performed by an independent specialist midwife who was unaware of group allocation. Statistical analyses were conducted by an independent statistician blinded to the group assignments. After completion of the analyses, group codes were revealed and the results were interpreted. Due to the nature of the intervention, blinding of participants and the researcher delivering Motivational Interviewing (MI) was not possible. However, to minimize potential bias, outcome assessment, data entry, and statistical analyses were conducted by independent researchers who were unaware of group assignments. Recruitment and data collection Research data were obtained using the Personal Information Form, SRAHPS, and SF-36. The Personal Information Form was prepared by the researchers based on a comprehensive review of the relevant literature [27–29]. The form was designed to collect information on characteristics that may influence health management self-efficacy and quality of life during pregnancy. It consisted of 15 questions, including 11 items related to sociodemographic characteristics (age, education level, family type, employment status, income status, and smoking status) and 4 items related to obstetric characteristics (gestational week, gravidity, parity, and body mass index). The SRAHPS was developed by Becker et al. (1993) to assess individuals’ self-efficacy regarding health-promoting behaviours such as nutrition, physical activity, psychological well-being, and health responsibility [30]. The scale consists of 28 items and four subscales: nutrition (items 1–7), psychological well-being (items 8–14), exercise (items 15–21), and health responsibility (items 22–28). Items are rated on a 5-point Likert scale from 0 (never) to 4 (completely). Total scores range from 0–112, and subscale scores range from 0–28, with higher scores indicating greater self-efficacy. The Turkish validity and reliability study reported a Cronbach’s alpha of 0.91 [31]. In the present study, Cronbach’s alpha was 0.83. This scale was selected because it comprehensively evaluates self-efficacy related to health-promoting behaviours, including nutrition, exercise, psychological well-being, and health responsibility, which are essential components of gestational diabetes management. The SF-36 was developed by Ware and Sherbourne (1992) to assess quality of life [32]. The Turkish version has been widely used in clinical practice, research, and health policy evaluation and has also been used to assess quality of life in women with GDM. The scale consists of 36 items and eight subscales: physical functioning, social functioning, role limitations due to physical problems, role limitations due to emotional problems, mental health, vitality, pain, and general health perception. Each subscale is scored between 0–100, with higher scores indicating better quality of life. The Turkish validity and reliability study reported a Cronbach’s alpha of 0.92 [33]. In this study, Cronbach’s alpha was calculated as 0.82. The instrument was chosen because it is one of the most widely used generic quality-of-life measures and enables assessment of both physical and mental health dimensions potentially affected by gestational diabetes mellitus. Prior to data collection, permission to use the Turkish versions of the SRAHPS and SF-36 was obtained via e-mail from the authors who conducted the Turkish validity and reliability studies of these instruments. Data were collected at three time points: baseline (pre-intervention), immediately after completion of the intervention, and four weeks post-intervention (follow-up). At baseline, the Personal Information Form, SRAHPS, and SF-36 were administered to both groups. The intervention group received four weekly MI sessions over four weeks, while the control group received routine care only. After completion of the intervention, SRAHPS and SF-36 were re-administered as post-tests. No intervention was applied to either group during the subsequent four weeks, and follow-up data were collected at the end of this period. The study flow diagram is presented in Fig. 2.Fig. 2Participant flow diagram Participant flow diagram Intervention group Pregnant women assigned to the intervention group received individual counselling based on MI delivered by the researcher. The intervention was planned as four sessions conducted once weekly over four weeks. Sessions were conducted face-to-face in a quiet room within the hospital where privacy was ensured, and each session lasted approximately 20–40 min. In addition to MI, participants in the intervention group continued to receive routine antenatal care. The MI sessions were structured to strengthen intrinsic motivation for change and included determining intention to change, supporting motivation, goal setting, and evaluating maintenance of change. During sessions, women’s perceptions and emotional responses to the GDM diagnosis were addressed, and ambivalence regarding nutrition, physical activity, and self-care behaviours was explored using MI techniques. Open-ended questions, reflective listening, and summarizing techniques were used to elicit change talk, and individualized, achievable goals were collaboratively established. The intervention was conducted by the principal investigator, a certified midwife trained in MI and experienced in maternal health. To ensure intervention fidelity and standardization, all sessions were delivered by the same practitioner in accordance with a pre-prepared intervention protocol. To support the MI process, an educational booklet on GDM management was developed by the researchers based on current guidelines and evidence-based literature. The booklet included information on the importance of GDM, blood glucose control, nutrition and physical activity recommendations, glucose monitoring, treatment adherence, and postpartum care. The content was prepared in clear language and supported with visuals. The MI session content and educational booklet were reviewed by 11 academic experts in the field, and final revisions were made in accordance with their recommendations. Details of the MI sessions are presented in Table 1.Table 1Content of the MI interventionMI Sessions and TimingDurationAimContentSession 1: Establishing Rapport and Exploring Readiness for Change30–40 minTo enable the pregnant woman to express her thoughts and perceptions regarding GDM, and to assess her intention and perceived importance of change• Introduction and explanation of the interview process• Assessment of perceptions regarding change• Raising awareness about GDM through open-ended questions• Providing information when necessary• Assignment of home-based tasksSession 2: Strengthening Intrinsic Motivation(Conducted one week after Session 1)20–30 minTo enhance motivation for change, increase awareness of ambivalence, and support commitment to change• Review of Session 1 and evaluation of assigned tasks• Assessment of perceptions regarding change• Enhancing awareness of the benefits of change• Providing an empathetic approach to pregnant women not ready for change• Assignment of home-based tasksSession 3: Planning and Supporting Change(Conducted one week after Session 2)20–30 minTo structure the change process and reinforce commitment to change• Review of the first two sessions and evaluation of progress• Assessment of commitment to change• Identification of goals and change options• Enhancing awareness of available social support resources• Assignment of home-based tasksSession 4: Evaluation and Maintenance of Change(Conducted one week after Session 3)20–30 minTo evaluate the change process, strengthen commitment, and sustain motivation• Overall review of previous sessions and the change plan• Discussion of positive and negative experiences• Affirmation of efforts made toward lifestyle changes related to GDM• Encouragement to maintain behavioral change Table 1Content of the MI interventionMI Sessions and TimingDurationAimContentSession 1: Establishing Rapport and Exploring Readiness for Change30–40 minTo enable the pregnant woman to express her thoughts and perceptions regarding GDM, and to assess her intention and perceived importance of change• Introduction and explanation of the interview process• Assessment of perceptions regarding change• Raising awareness about GDM through open-ended questions• Providing information when necessary• Assignment of home-based tasksSession 2: Strengthening Intrinsic Motivation(Conducted one week after Session 1)20–30 minTo enhance motivation for change, increase awareness of ambivalence, and support commitment to change• Review of Session 1 and evaluation of assigned tasks• Assessment of perceptions regarding change• Enhancing awareness of the benefits of change• Providing an empathetic approach to pregnant women not ready for change• Assignment of home-based tasksSession 3: Planning and Supporting Change(Conducted one week after Session 2)20–30 minTo structure the change process and reinforce commitment to change• Review of the first two sessions and evaluation of progress• Assessment of commitment to change• Identification of goals and change options• Enhancing awareness of available social support resources• Assignment of home-based tasksSession 4: Evaluation and Maintenance of Change(Conducted one week after Session 3)20–30 minTo evaluate the change process, strengthen commitment, and sustain motivation• Overall review of previous sessions and the change plan• Discussion of positive and negative experiences• Affirmation of efforts made toward lifestyle changes related to GDM• Encouragement to maintain behavioral change Content of the MI intervention • Introduction and explanation of the interview process • Assessment of perceptions regarding change • Raising awareness about GDM through open-ended questions • Providing information when necessary • Assignment of home-based tasks Session 2: Strengthening Intrinsic Motivation (Conducted one week after Session 1) • Review of Session 1 and evaluation of assigned tasks • Assessment of perceptions regarding change • Enhancing awareness of the benefits of change • Providing an empathetic approach to pregnant women not ready for change • Assignment of home-based tasks Session 3: Planning and Supporting Change (Conducted one week after Session 2) • Review of the first two sessions and evaluation of progress • Assessment of commitment to change • Identification of goals and change options • Enhancing awareness of available social support resources • Assignment of home-based tasks Session 4: Evaluation and Maintenance of Change (Conducted one week after Session 3) • Overall review of previous sessions and the change plan • Discussion of positive and negative experiences • Affirmation of efforts made toward lifestyle changes related to GDM • Encouragement to maintain behavioral change Control group Pregnant women in the control group received only routine antenatal care. No MI or additional education was provided. Only SRAHPS and SF-36 measurements were administered. Statistical analysis Data were analysed using SPSS version 22.0. Descriptive statistics were presented as mean, standard deviation, frequency, and percentage. Normality was assessed using the Shapiro–Wilk test and skewness–kurtosis coefficients. Since the data were normally distributed, parametric tests were used. Relationships between categorical variables were analysed using the chi-square test. Independent samples t-test and one-way ANOVA were used for comparisons between intervention and control groups where appropriate. Repeated measures ANOVA was used to evaluate changes over time (pre-test, post-test, follow-up). Sphericity was assessed using Mauchly’s test, and the Greenhouse–Geisser correction was applied when the assumption was violated. Statistical significance was set at p < 0.05. Ethical considerations Ethical approval for the study was obtained from a University Non-Interventional Clinical Research Ethics Committee (Date: 02.06.2023). Permissions were secured from the authors who conducted the Turkish validity and reliability studies of the scales used in the research. Permission was obtained via e-mail prior to data collection. Data collection was conducted in accordance with the Declaration of Helsinki. Institutional permissions were obtained from the participating hospitals. Written informed consent was obtained from all participants. The study was registered at ClinicalTrials.gov (ID: NCT06243939). The manuscript was prepared in accordance with the CONSORT 2025 reporting guideline [34]. Results The study was completed with a total of 60 participants, including 30 in the intervention group and 30 in the control group. The mean height of the pregnant women was 163.25 ± 5.41 cm, and the mean pre-pregnancy weight was 78.71 ± 17.74 kg. At the first follow-up, the current mean weight was 86.05 ± 18.04 kg. The mean pre-pregnancy body mass index (BMI) was 29.49 ± 6.21 kg/m2, and the current BMI was 32.29 ± 6.22 kg/m2. The mean gestational week was 25.10 ± 1.25, the mean number of pregnancies was 3.13 ± 1.28, and the mean number of living children was 1.80 ± 1.03. It was determined that 40% of the participants were high school graduates, 91.7% had a nuclear family structure, 78.3% were unemployed, 60% reported income equal to expenses, and 96.7% did not smoke. When the intervention and control groups were compared in terms of sociodemographic and obstetric characteristics such as age, education level, family type, employment status, number of pregnancies, number of living children, gestational week, and body mass index, no statistically significant differences were found between the groups (p > 0.05) (Table 2).Table 2Comparison of Sociodemographic and Obstetric Characteristics of Pregnant Women in the Intervention and Control Groups (N = 60)VariablesIntervention Group(n = 30)Control Group(n = 30)Total(n = 30)Test StatistictpMean ± SDMin-MaxMean ± SDMin–MaxMean ± SDMin–MaxAge33.14 ± 6.5221–4333.63 ± 6.3320–4433.40 ± 6.3820–44-.2810.780Height165.33 ± 5.30151–170163.16 ± 6.51150–173163.25 ± 5.41150–173.1180.906Pre-pregnancy weight78.06 ± 19.4843–14079.36 ± 16.1256–12078.71 ± 17.7443–140-.2820.779Current weight86.73 ± 18.3753–14089.73 ± 15.1360–13186.05 ± 18.0453–140.2910.772Pre-pregnancy BMI29.19 ± 6.7315.80–50.8029.79 ± 5.7418.90–44.0029.49 ± 6.2115.80–50.80-.3690. 713Current BMI30.50 ± 6.2319.50–50.8032.07 ± 6.3121.90–48.1032.29 ± 6.2219.50–50.80.2670.790Gestational week24.93 ± 0.9023–2625.26 ± 2.4822–2725.10 ± 1.2522–27−1.0270.390Gravidity3.20 ± 1.341–83.02 ± 1.221–53.13 ± 1.281–8.4000.691Parity1.93 ± 1.010–41.66 ± 1.060–41.80 ± 1.030–4.9950.324n%n%n%Test statisticX2pEducational status Literate1%3.31%3.32%3.3 Primary school or below7%23.37%23.314%23.3X2 = 1.8130.829 Middle school5%16.78%26.713%21.7 High school14%46.710%33.324%40.0 University3%10.04%13.37%11.7Family type Nuclear family27%90.028%93.355%91.7X2 = 0.000 > 0.999 Extended family3%10.02%6.75%8.3Employment status Employed6%207%23.313%21.7X2 = 0980.754 Unemployed24%8023%76.747%78.3Income status Income greater than expenses1%3.33%10.04%6.7X2 = 1.5890.439 Income equal to expenses20%66.716%53.336%60.0 Income less than expenses9%30.011%36.720%33.3Smoking status Smoker1%3.31%3.32%3.3X2 = 0.000 > 0.999 Non-smoker29%96.729%96.758%96.7p < 0.05 was considered statistically significantMean mean, SD standard deviation, min minimum, max maximum, n number, % percentage, χ2 chi-square test, t independent samples t-test Table 2Comparison of Sociodemographic and Obstetric Characteristics of Pregnant Women in the Intervention and Control Groups (N = 60)VariablesIntervention Group(n = 30)Control Group(n = 30)Total(n = 30)Test StatistictpMean ± SDMin-MaxMean ± SDMin–MaxMean ± SDMin–MaxAge33.14 ± 6.5221–4333.63 ± 6.3320–4433.40 ± 6.3820–44-.2810.780Height165.33 ± 5.30151–170163.16 ± 6.51150–173163.25 ± 5.41150–173.1180.906Pre-pregnancy weight78.06 ± 19.4843–14079.36 ± 16.1256–12078.71 ± 17.7443–140-.2820.779Current weight86.73 ± 18.3753–14089.73 ± 15.1360–13186.05 ± 18.0453–140.2910.772Pre-pregnancy BMI29.19 ± 6.7315.80–50.8029.79 ± 5.7418.90–44.0029.49 ± 6.2115.80–50.80-.3690. 713Current BMI30.50 ± 6.2319.50–50.8032.07 ± 6.3121.90–48.1032.29 ± 6.2219.50–50.80.2670.790Gestational week24.93 ± 0.9023–2625.26 ± 2.4822–2725.10 ± 1.2522–27−1.0270.390Gravidity3.20 ± 1.341–83.02 ± 1.221–53.13 ± 1.281–8.4000.691Parity1.93 ± 1.010–41.66 ± 1.060–41.80 ± 1.030–4.9950.324n%n%n%Test statisticX2pEducational status Literate1%3.31%3.32%3.3 Primary school or below7%23.37%23.314%23.3X2 = 1.8130.829 Middle school5%16.78%26.713%21.7 High school14%46.710%33.324%40.0 University3%10.04%13.37%11.7Family type Nuclear family27%90.028%93.355%91.7X2 = 0.000 > 0.999 Extended family3%10.02%6.75%8.3Employment status Employed6%207%23.313%21.7X2 = 0980.754 Unemployed24%8023%76.747%78.3Income status Income greater than expenses1%3.33%10.04%6.7X2 = 1.5890.439 Income equal to expenses20%66.716%53.336%60.0 Income less than expenses9%30.011%36.720%33.3Smoking status Smoker1%3.31%3.32%3.3X2 = 0.000 > 0.999 Non-smoker29%96.729%96.758%96.7p < 0.05 was considered statistically significantMean mean, SD standard deviation, min minimum, max maximum, n number, % percentage, χ2 chi-square test, t independent samples t-test Comparison of Sociodemographic and Obstetric Characteristics of Pregnant Women in the Intervention and Control Groups (N = 60) p < 0.05 was considered statistically significant Mean mean, SD standard deviation, min minimum, max maximum, n number, % percentage, χ2 chi-square test, t independent samples t-test There was no statistically significant difference between the intervention and control groups in the pre-test mean scores of the SRAHPS total and its subscales (p > 0.05). However, following MI, the intervention group demonstrated statistically significant increases in the exercise, health responsibility, psychological well-being, and nutrition subscales, as well as in the total SRAHPS scores at post-test and follow-up compared to the control group (p < 0.05). In contrast, the control group did not show a significant increase over time (p > 0.05), and a decreasing trend was observed in some subscales (Table 3).Table 3Comparison of Within-Group and Between-Group Findings of Pregnant Women’s SRAHPS Pre-Test, Post-Test, and Follow-Up Test Mean Scores and Results Regarding Group, Time, and Group*Time Interaction (N = 60)SRAHPSSubdimensionsInterventionGroup(n = 30)ControlGroup(n = 30)Test StatisticpComparison of Repeated MeasuresAccording to Group. Time. andGroup*TimeMean ± SDMean ± SDtη2GroupTimeGroup*TimeExercisePre-Test13.30 ± 5.3414.06 ± 6.70-.5410.0050.590F: 9.741**p: < 0.001η2p:0.144F: 10.149**p: < 0.001η2p: 0.149F: 24.127**p: < 0.001η2p: 0.294Post-Test18.26 ± 2.6313.36 ± 6.393.8810.206 < 0.001Follow-UpTest18.93 ± 2.1812.60 ± 5.895.5160.344 < 0.001WithinGroupF** = 25.644p = < 0.001η2 = 0.469F* = 2.506p = 0.090η2 = 0.080Responsibilityfor HealthPracticesPre-Test20.63 ± 4.6721.36 ± 4.90-.5930.0060.556F: 2.644**p: 0.109η2p: 0.044F: 8.232**p: < 0.001η2p: 0.124F: 4.267**p: 0.026η2p: 0.069Post-Test24.10 ± 1.5321.93 ± 4.892.3110.0840.024Follow-UpTest24.53 ± 1.5922.00 ± 5.452.4430.0930.018WithinGroupF** = 18.997p = < 0.001η2 = 0.396F** = 0.237p = 0.731η2 = 0.008PsychologicalWell-BeingPre-Test18.43 ± 4.4818.93 ± 5.27-.3950.0030.694F: 25.056**p: < 0.001η2p: 0.302F: 12.510**p: < 0.001η2p: 0.177F: 37.876**p: < 0.001η2p: 0.395Post-Test24.90 ± 2.1817.50 ± 5.456.9020.451 < 0.001Follow-UpTest24.63 ± 3.1716.86 ± 5.276.9060.451 < 0.001WithinGroupF** = 47.473p = < 0.001η2 = 0.621F** = 3.814p = 0.037η2 = 0.116NutritionPre-Test18.36 ± 5.3418.63 ± 6.70-.1890.0010.851F: 14.177**p: 0.001η2p: 0.162F: 63.483**p: < 0.001η2p: 0.523F: 34.683**p: < 0.001η2p: 0.374Post-Test25.03 ± 2.3419.60 ± 4.835.4430.338 < 0.001Follow-UpTest25.03 ± 2.3419.60 ± 4.835.5420.346 < 0.001WithinGroupF** = 66.590p = < 0.001η2 = 0.697F* = 3.881p = 0.026η2 = 0.118Total SRAHPSScorePre-Test70.73 ± 16.4573.00 ± 18.63-.4990.0040.619F: 14.815**p: < 0.001η2p: 0.203F: 35.400**p: < 0.001η2p: 0.379F: 44.599**p: < 0.001η2p: 0.435Post-Test92.30 ± 5.3372.46 ± 17.955.7990.367 < 0.001Follow-UpTest93.13 ± 6.2171.06 ± 17.216.6040.429 < 0.001WithinGroupF** = 66.837p = < 0.001η2 = 0.697F** = 0.607p = 0.499η2 = 0.020p < 0.05 was considered statistically significant. Values presented in bold indicate statistically significant differences (p < 0.05)Mean mean, SD standard deviation, t independent samples t-test statistic, η2 eta squared effect size for independent samples t-test comparisons, F repeated measures analysis of variance (ANOVA), η2p partial eta squared effect size for repeated measures ANOVA analyses*Sphericity assumed**Greenhouse–Geisser correction applied Table 3Comparison of Within-Group and Between-Group Findings of Pregnant Women’s SRAHPS Pre-Test, Post-Test, and Follow-Up Test Mean Scores and Results Regarding Group, Time, and Group*Time Interaction (N = 60)SRAHPSSubdimensionsInterventionGroup(n = 30)ControlGroup(n = 30)Test StatisticpComparison of Repeated MeasuresAccording to Group. Time. andGroup*TimeMean ± SDMean ± SDtη2GroupTimeGroup*TimeExercisePre-Test13.30 ± 5.3414.06 ± 6.70-.5410.0050.590F: 9.741**p: < 0.001η2p:0.144F: 10.149**p: < 0.001η2p: 0.149F: 24.127**p: < 0.001η2p: 0.294Post-Test18.26 ± 2.6313.36 ± 6.393.8810.206 < 0.001Follow-UpTest18.93 ± 2.1812.60 ± 5.895.5160.344 < 0.001WithinGroupF** = 25.644p = < 0.001η2 = 0.469F* = 2.506p = 0.090η2 = 0.080Responsibilityfor HealthPracticesPre-Test20.63 ± 4.6721.36 ± 4.90-.5930.0060.556F: 2.644**p: 0.109η2p: 0.044F: 8.232**p: < 0.001η2p: 0.124F: 4.267**p: 0.026η2p: 0.069Post-Test24.10 ± 1.5321.93 ± 4.892.3110.0840.024Follow-UpTest24.53 ± 1.5922.00 ± 5.452.4430.0930.018WithinGroupF** = 18.997p = < 0.001η2 = 0.396F** = 0.237p = 0.731η2 = 0.008PsychologicalWell-BeingPre-Test18.43 ± 4.4818.93 ± 5.27-.3950.0030.694F: 25.056**p: < 0.001η2p: 0.302F: 12.510**p: < 0.001η2p: 0.177F: 37.876**p: < 0.001η2p: 0.395Post-Test24.90 ± 2.1817.50 ± 5.456.9020.451 < 0.001Follow-UpTest24.63 ± 3.1716.86 ± 5.276.9060.451 < 0.001WithinGroupF** = 47.473p = < 0.001η2 = 0.621F** = 3.814p = 0.037η2 = 0.116NutritionPre-Test18.36 ± 5.3418.63 ± 6.70-.1890.0010.851F: 14.177**p: 0.001η2p: 0.162F: 63.483**p: < 0.001η2p: 0.523F: 34.683**p: < 0.001η2p: 0.374Post-Test25.03 ± 2.3419.60 ± 4.835.4430.338 < 0.001Follow-UpTest25.03 ± 2.3419.60 ± 4.835.5420.346 < 0.001WithinGroupF** = 66.590p = < 0.001η2 = 0.697F* = 3.881p = 0.026η2 = 0.118Total SRAHPSScorePre-Test70.73 ± 16.4573.00 ± 18.63-.4990.0040.619F: 14.815**p: < 0.001η2p: 0.203F: 35.400**p: < 0.001η2p: 0.379F: 44.599**p: < 0.001η2p: 0.435Post-Test92.30 ± 5.3372.46 ± 17.955.7990.367 < 0.001Follow-UpTest93.13 ± 6.2171.06 ± 17.216.6040.429 < 0.001WithinGroupF** = 66.837p = < 0.001η2 = 0.697F** = 0.607p = 0.499η2 = 0.020p < 0.05 was considered statistically significant. Values presented in bold indicate statistically significant differences (p < 0.05)Mean mean, SD standard deviation, t independent samples t-test statistic, η2 eta squared effect size for independent samples t-test comparisons, F repeated measures analysis of variance (ANOVA), η2p partial eta squared effect size for repeated measures ANOVA analyses*Sphericity assumed**Greenhouse–Geisser correction applied Comparison of Within-Group and Between-Group Findings of Pregnant Women’s SRAHPS Pre-Test, Post-Test, and Follow-Up Test Mean Scores and Results Regarding Group, Time, and Group*Time Interaction (N = 60) F: 9.741** p: < 0.001 η2p:0.144 F: 10.149** p: < 0.001 η2p: 0.149 F: 24.127** p: < 0.001 η2p: 0.294 Follow-Up Test Within Group F** = 25.644 p = < 0.001 η2 = 0.469 F* = 2.506 p = 0.090 η2 = 0.080 Responsibility for Health Practices F: 2.644** p: 0.109 η2p: 0.044 F: 8.232** p: < 0.001 η2p: 0.124 F: 4.267** p: 0.026 η2p: 0.069 Follow-Up Test Within Group F** = 18.997 p = < 0.001 η2 = 0.396 F** = 0.237 p = 0.731 η2 = 0.008 Psychological Well-Being F: 25.056** p: < 0.001 η2p: 0.302 F: 12.510** p: < 0.001 η2p: 0.177 F: 37.876** p: < 0.001 η2p: 0.395 Follow-Up Test Within Group F** = 47.473 p = < 0.001 η2 = 0.621 F** = 3.814 p = 0.037 η2 = 0.116 F: 14.177** p: 0.001 η2p: 0.162 F: 63.483** p: < 0.001 η2p: 0.523 F: 34.683** p: < 0.001 η2p: 0.374 Follow-Up Test Within Group F** = 66.590 p = < 0.001 η2 = 0.697 F* = 3.881 p = 0.026 η2 = 0.118 Total SRAHPS Score F: 14.815** p: < 0.001 η2p: 0.203 F: 35.400** p: < 0.001 η2p: 0.379 F: 44.599** p: < 0.001 η2p: 0.435 Follow-Up Test Within Group F** = 66.837 p = < 0.001 η2 = 0.697 F** = 0.607 p = 0.499 η2 = 0.020 p < 0.05 was considered statistically significant. Values presented in bold indicate statistically significant differences (p < 0.05) Mean mean, SD standard deviation, t independent samples t-test statistic, η2 eta squared effect size for independent samples t-test comparisons, F repeated measures analysis of variance (ANOVA), η2p partial eta squared effect size for repeated measures ANOVA analyses *Sphericity assumed **Greenhouse–Geisser correction applied In repeated measures analysis, significant group, time, and group x time interaction effects were found for the SRAHPS exercise, psychological well-being, and nutrition subscales, as well as for the total scale score (p < 0.001). For the health responsibility subscale, time and group x time interaction effects were significant (p < 0.05), whereas the group effect was not statistically significant (p > 0.05) (Table 3). Findings regarding the comparison of pre-test, post-test, and follow-up mean scores of the subscales of the SF-36 between the intervention and control groups are presented in Table 4. At baseline, no statistically significant differences were found between the groups in any of the SF-36 subscales (p > 0.05). However, at post-test and follow-up, the intervention group had significantly higher scores than the control group in the physical functioning, vitality, mental health, social functioning, and general health perception subscales (p < 0.05). A statistically significant difference between the groups was found in the role-emotional subscale (p < 0.05), whereas no statistically significant difference was observed in the role-physical subscale (p > 0.05). Although the difference between groups was not statistically significant in the pain subscale (p > 0.05), significant time and group × time interaction effects were found (p < 0.05).Table 4Comparison of Within-Group and Between-Group Findings of Pregnant Women’s SF-36 Pre-Test, Post-Test, and Follow-Up Test Mean Scores and Results Regarding Group, Time, and Group*Time Interaction (N = 60)SF-36SubdimensionsInterventionGroup(n = 30)ControlGroup(n = 30)Test StatisticpComparison of Repeated MeasuresAccording to Group. Time. andGroup*TimeMean ± SDMean ± SDtη2GroupTimeGroup*TimePhysicalFunctioningPre-Test46.50 ± 25.3646.66 ± 15.04-.0310.0000.975F: 9.471**p: 0.003η2p: 0.140F: 3.855**p: 0.029η2p: 0.062F: 6.911**p: 0.002η2p: 0.106Post-Test60.16 ± 9.5145.33 ± 15.474.4720.246 < 0.001Follow-UpTest59.66 ± 16.0244.00 ± 14.283.9970.216 < 0.001WithinGroupF** = 7.243p = 0.004η2 = 0.200F* = 0.556p = 0.576η2 = 0.019RoleLimitationsDue toPhysicalProblemsPre-Test48.51 ± 30.0644.16 ± 33.270.5310.0050.597F: 4.069*p: 0.048η2p: 0.066F: 1.519*p: 0.223η2p: 0.026F: 0.759*p: 0.470η2p: 0.013Post-Test61.66 ± 29.1646.66 ± 32.651.8770.0570.066Follow-UpTest60.20 ± 30.8245.83 ± 27.131.9160.0600.060WithinGroupF* = 1.927p = 0.155η2 = 0.062F* = 0.081p = 0.923η2 = 0.003RoleLimitationsDue toEmotionalProblemsPre-Test33.33 ± 26.2634.44 ± 32.14-.1470.0000.884F: 4.257*p: 0.044η2p: 0.068F: 2.586*p: 0.080η2p: 0.043F: 2.948*p: 0.056η2p: 0.048Post-Test52.22 ± 29.9233.33 ± 33.902.2880.0830.026Follow-UpTest51.14 ± 31.2534.00 ± 22.282.3830.0890.20WithinGroupF* = 6.972p = 0.002η2 = 0.194F* = 0.017p = 0.983η2 = 0.001EnergyPre-Test44.00 ± 15.4446.16 ± 17.25-.5120.0050.610F: 6.912**p: 0.011η2p: 0.106F: 17.920**p: < 0.001η2p: 0.236F: 19.218**p: < 0.001η2p: 0.249Post-Test60.50 ± 8.2346.33 ± 15.134.5020.259 < 0.001Follow-UpTest58.00 ± 10.1345.16 ± 14.593.9560.213 < 0.001WithinGroupF* = 30.321p = < 0.001η2 = 0.511F** = 0.238p = 0.747η2 = 0.008MentalHealthPre-Test57.60 ± 11.2459.46 ± 12.54-.6070.0060.546F: 8.606**p: 0.005η2p: 0.129F: 19.438**p: < 0.001η2p: 0.251F: 22.968**p: < 0.001η2p: 0.284Post-Test70.53 ± 7.0860.66 ± 10.404.2940.241 < 0.001Follow-UpTest68.93 ± 8.4456.26 ± 11.744.7960.284 < 0.001WithinGroupF** = 30.791p = < 0.001η2 = 0.515F* = 5.311p = 0.008η2 = 0.155SocialFunctioningPre-Test57.08 ± 22.4257.50 ± 22.84-.0710.0000.943F: 2.091**p: 0.154η2p: 0.035F: 7.187**p: 0.002η2p: 0.110F: 10.379**p: < 0.001η2p: 0.152Post-Test68.33 ± 15.9956.48 ± 19.672.5600.1010.013Follow-UpTest65.83 ± 16.3956.66 ± 18.192.0500.0680.045WithinGroupF** = 14.609p = < 0.001η2 = 0.335F* = 0.181p = 0.812η2 = 0.006PainPre-Test59.33 ± 17.5460.66 ± 16.82-.3000.0020.765F: 0.966**p: 0.330η2p: 0.016F: 4.153**p: 0.027η2p: 0.067F: 7.004**p: 0.003η2p: 0.108Post-Test66.66 ± 12.7060.00 ± 16.461.7560.0500.084Follow-UpTest64.66 ± 11.9959.08 ± 15.071.5870.0420.118WithinGroupF** = 7.002p = 0.009η2 = 0.194F** = 0.992p = 0.362η2 = 0.033General Health PerceptionPre-Test45.83 ± 11.8250.00 ± 13.13−1.2920.0280.202F: 19.605**p: < 0.001η2p: 0.253F: 16.750**p: < 0.001η2p: 0.224F: 40.067**p: < 0.001η2p: 0.409Post-Test64.66 ± 7.8747.32 ± 11.656.7540.440 < 0.001Follow-UpTest60.33 ± 8.7042.62 ± 11.656.6690.434 < 0.001WithinGroupF* = 60.541p = < 0.001η2 = 0.676F** = 6.046p = 0.007η2 = 0,173p < 0.05 was considered statistically significant. Values presented in bold indicate statistically significant differences (p < 0.05)Mean mean, SD standard deviation, t independent samples t-test statistic, η2 eta squared effect size for independent samples t-test comparisons, F repeated measures analysis of variance (ANOVA), η2p partial eta squared effect size for repeated measures ANOVA analyses* Sphericity assumed** Greenhouse–Geisser correction applied Table 4Comparison of Within-Group and Between-Group Findings of Pregnant Women’s SF-36 Pre-Test, Post-Test, and Follow-Up Test Mean Scores and Results Regarding Group, Time, and Group*Time Interaction (N = 60)SF-36SubdimensionsInterventionGroup(n = 30)ControlGroup(n = 30)Test StatisticpComparison of Repeated MeasuresAccording to Group. Time. andGroup*TimeMean ± SDMean ± SDtη2GroupTimeGroup*TimePhysicalFunctioningPre-Test46.50 ± 25.3646.66 ± 15.04-.0310.0000.975F: 9.471**p: 0.003η2p: 0.140F: 3.855**p: 0.029η2p: 0.062F: 6.911**p: 0.002η2p: 0.106Post-Test60.16 ± 9.5145.33 ± 15.474.4720.246 < 0.001Follow-UpTest59.66 ± 16.0244.00 ± 14.283.9970.216 < 0.001WithinGroupF** = 7.243p = 0.004η2 = 0.200F* = 0.556p = 0.576η2 = 0.019RoleLimitationsDue toPhysicalProblemsPre-Test48.51 ± 30.0644.16 ± 33.270.5310.0050.597F: 4.069*p: 0.048η2p: 0.066F: 1.519*p: 0.223η2p: 0.026F: 0.759*p: 0.470η2p: 0.013Post-Test61.66 ± 29.1646.66 ± 32.651.8770.0570.066Follow-UpTest60.20 ± 30.8245.83 ± 27.131.9160.0600.060WithinGroupF* = 1.927p = 0.155η2 = 0.062F* = 0.081p = 0.923η2 = 0.003RoleLimitationsDue toEmotionalProblemsPre-Test33.33 ± 26.2634.44 ± 32.14-.1470.0000.884F: 4.257*p: 0.044η2p: 0.068F: 2.586*p: 0.080η2p: 0.043F: 2.948*p: 0.056η2p: 0.048Post-Test52.22 ± 29.9233.33 ± 33.902.2880.0830.026Follow-UpTest51.14 ± 31.2534.00 ± 22.282.3830.0890.20WithinGroupF* = 6.972p = 0.002η2 = 0.194F* = 0.017p = 0.983η2 = 0.001EnergyPre-Test44.00 ± 15.4446.16 ± 17.25-.5120.0050.610F: 6.912**p: 0.011η2p: 0.106F: 17.920**p: < 0.001η2p: 0.236F: 19.218**p: < 0.001η2p: 0.249Post-Test60.50 ± 8.2346.33 ± 15.134.5020.259 < 0.001Follow-UpTest58.00 ± 10.1345.16 ± 14.593.9560.213 < 0.001WithinGroupF* = 30.321p = < 0.001η2 = 0.511F** = 0.238p = 0.747η2 = 0.008MentalHealthPre-Test57.60 ± 11.2459.46 ± 12.54-.6070.0060.546F: 8.606**p: 0.005η2p: 0.129F: 19.438**p: < 0.001η2p: 0.251F: 22.968**p: < 0.001η2p: 0.284Post-Test70.53 ± 7.0860.66 ± 10.404.2940.241 < 0.001Follow-UpTest68.93 ± 8.4456.26 ± 11.744.7960.284 < 0.001WithinGroupF** = 30.791p = < 0.001η2 = 0.515F* = 5.311p = 0.008η2 = 0.155SocialFunctioningPre-Test57.08 ± 22.4257.50 ± 22.84-.0710.0000.943F: 2.091**p: 0.154η2p: 0.035F: 7.187**p: 0.002η2p: 0.110F: 10.379**p: < 0.001η2p: 0.152Post-Test68.33 ± 15.9956.48 ± 19.672.5600.1010.013Follow-UpTest65.83 ± 16.3956.66 ± 18.192.0500.0680.045WithinGroupF** = 14.609p = < 0.001η2 = 0.335F* = 0.181p = 0.812η2 = 0.006PainPre-Test59.33 ± 17.5460.66 ± 16.82-.3000.0020.765F: 0.966**p: 0.330η2p: 0.016F: 4.153**p: 0.027η2p: 0.067F: 7.004**p: 0.003η2p: 0.108Post-Test66.66 ± 12.7060.00 ± 16.461.7560.0500.084Follow-UpTest64.66 ± 11.9959.08 ± 15.071.5870.0420.118WithinGroupF** = 7.002p = 0.009η2 = 0.194F** = 0.992p = 0.362η2 = 0.033General Health PerceptionPre-Test45.83 ± 11.8250.00 ± 13.13−1.2920.0280.202F: 19.605**p: < 0.001η2p: 0.253F: 16.750**p: < 0.001η2p: 0.224F: 40.067**p: < 0.001η2p: 0.409Post-Test64.66 ± 7.8747.32 ± 11.656.7540.440 < 0.001Follow-UpTest60.33 ± 8.7042.62 ± 11.656.6690.434 < 0.001WithinGroupF* = 60.541p = < 0.001η2 = 0.676F** = 6.046p = 0.007η2 = 0,173p < 0.05 was considered statistically significant. Values presented in bold indicate statistically significant differences (p < 0.05)Mean mean, SD standard deviation, t independent samples t-test statistic, η2 eta squared effect size for independent samples t-test comparisons, F repeated measures analysis of variance (ANOVA), η2p partial eta squared effect size for repeated measures ANOVA analyses* Sphericity assumed** Greenhouse–Geisser correction applied Comparison of Within-Group and Between-Group Findings of Pregnant Women’s SF-36 Pre-Test, Post-Test, and Follow-Up Test Mean Scores and Results Regarding Group, Time, and Group*Time Interaction (N = 60) Physical Functioning F: 9.471** p: 0.003 η2p: 0.140 F: 3.855** p: 0.029 η2p: 0.062 F: 6.911** p: 0.002 η2p: 0.106 Follow-Up Test Within Group F** = 7.243 p = 0.004 η2 = 0.200 F* = 0.556 p = 0.576 η2 = 0.019 Role Limitations Due to Physical Problems F: 4.069* p: 0.048 η2p: 0.066 F: 1.519* p: 0.223 η2p: 0.026 F: 0.759* p: 0.470 η2p: 0.013 Follow-Up Test Within Group F* = 1.927 p = 0.155 η2 = 0.062 F* = 0.081 p = 0.923 η2 = 0.003 Role Limitations Due to Emotional Problems F: 4.257* p: 0.044 η2p: 0.068 F: 2.586* p: 0.080 η2p: 0.043 F: 2.948* p: 0.056 η2p: 0.048 Follow-Up Test Within Group F* = 6.972 p = 0.002 η2 = 0.194 F* = 0.017 p = 0.983 η2 = 0.001 F: 6.912** p: 0.011 η2p: 0.106 F: 17.920** p: < 0.001 η2p: 0.236 F: 19.218** p: < 0.001 η2p: 0.249 Follow-Up Test Within Group F* = 30.321 p = < 0.001 η2 = 0.511 F** = 0.238 p = 0.747 η2 = 0.008 Mental Health F: 8.606** p: 0.005 η2p: 0.129 F: 19.438** p: < 0.001 η2p: 0.251 F: 22.968** p: < 0.001 η2p: 0.284 Follow-Up Test Within Group F** = 30.791 p = < 0.001 η2 = 0.515 F* = 5.311 p = 0.008 η2 = 0.155 Social Functioning F: 2.091** p: 0.154 η2p: 0.035 F: 7.187** p: 0.002 η2p: 0.110 F: 10.379** p: < 0.001 η2p: 0.152 Follow-Up Test Within Group F** = 14.609 p = < 0.001 η2 = 0.335 F* = 0.181 p = 0.812 η2 = 0.006 F: 0.966** p: 0.330 η2p: 0.016 F: 4.153** p: 0.027 η2p: 0.067 F: 7.004** p: 0.003 η2p: 0.108 Follow-Up Test Within Group F** = 7.002 p = 0.009 η2 = 0.194 F** = 0.992 p = 0.362 η2 = 0.033 F: 19.605** p: < 0.001 η2p: 0.253 F: 16.750** p: < 0.001 η2p: 0.224 F: 40.067** p: < 0.001 η2p: 0.409 Follow-Up Test Within Group F* = 60.541 p = < 0.001 η2 = 0.676 F** = 6.046 p = 0.007 η2 = 0,173 p < 0.05 was considered statistically significant. Values presented in bold indicate statistically significant differences (p < 0.05) Mean mean, SD standard deviation, t independent samples t-test statistic, η2 eta squared effect size for independent samples t-test comparisons, F repeated measures analysis of variance (ANOVA), η2p partial eta squared effect size for repeated measures ANOVA analyses * Sphericity assumed ** Greenhouse–Geisser correction applied According to repeated measures analysis, group, time, and group × time interaction effects were statistically significant for the physical functioning, vitality, mental health, and general health perception subscales (p < 0.05). In the social functioning subscale, time and group × time interaction effects were significant (p < 0.05), whereas the group effect was not significant. In the role-physical and role-emotional subscales, only the group effect was found to be statistically significant (p < 0.05). Discussion This study aimed to address an important gap in the literature regarding the integration of MI into midwifery and nursing care by evaluating its effects on self-efficacy in health management and quality of life among pregnant women diagnosed with GDM. In the present study, exercise subdimension scores of the SRAHPS significantly increased in the intervention group following the intervention and at follow-up, whereas no change was observed over time in the control group. The statistically significant group x time interaction and the large effect size (η2p = 0.294) indicate that MI was effective in strengthening exercise behaviors among pregnant women [35]. Similarly, in a study conducted by Smith et al. (2024), an intervention program combining MI with a digital application called “Stay-Active” was reported to increase physical activity levels in women with GDM. Eighty-five percent of participants found the application beneficial, and high participation in physical activity was emphasized [36]. This similarity suggests that MI can be effectively used either alone or in combination with digital tools to support behavior change. In this study, MI was found to be effective in increasing scores in the health responsibility subdimension of the SRAHPS. The significant increase in post-intervention and follow-up scores in the intervention group indicates that MI positively improved health behaviors. In contrast, no significant change was observed over time in the control group. Moreover, the moderate effect size of the group x time interaction in the health responsibility subdimension (η2p = 0.069) suggests that MI may strengthen pregnant women’s tendency to assume responsibility for their health [35]. Health responsibility is defined as an individual’s conscious decision-making to protect and promote their health, adoption of healthy lifestyle behaviors, and active engagement in acquiring, implementing, and maintaining health-related knowledge [37]. The literature also indicates that MI is effective in changing health behaviors, improving self-care and self-management skills, and enhancing behavioral outcomes in individuals with diabetes mellitus (DM) [18, 38, 39]. Consistent with these findings, the results of the present study suggest that MI may be a feasible method for enhancing health responsibility in pregnant women with GDM. In the intervention group, psychological well-being subdimension scores significantly increased after MI and at follow-up. The large effect size calculated for the group*time interaction (η2p = 0.395) indicates a strong effect of the intervention on psychological well-being [35]. Although a statistically significant change was also observed over time in the control group, the effect size was small [35]. The higher post-test and follow-up scores in the intervention group compared to the control group demonstrate that MI was effective in strengthening psychological well-being among pregnant women. Social support, particularly spousal support, is an important determinant of psychological well-being and anxiety levels in women diagnosed with GDM. A study conducted in Iran found that women with GDM perceived higher levels of social support from family and friends compared to the control group, and this support significantly reduced anxiety [40]. Furthermore, literature reviews indicate that women with higher levels of social support and self-efficacy demonstrate healthier dietary behaviors, increased physical activity, and better psychological well-being [11]. In this context, the significant change observed in the control group may be attributed to the positive influence of social support, particularly from spouses and close social networks. In the intervention group, nutrition subdimension scores significantly increased after MI and at follow-up. The large effect size for the group x time interaction (η2p = 0.374) indicates a strong impact of the intervention on nutritional behaviors [35]. Although a statistically significant increase was also observed over time in the control group, the effect size remained small. The higher post-test and follow-up scores in the intervention group compared to the control group demonstrate that MI was effective in improving dietary behaviors among pregnant women. The limited change observed in the control group may be attributed to nutritional education provided by a dietitian as part of routine care. Similarly, Di Onofrio et al. (2018) evaluated the effectiveness of an MI program in individuals with type 2 DM. After a nine-month intervention, participants developed positive habits such as consuming five meals per day and preferring fruit consumption; reductions were observed in sweetener and fructose use, daily energy intake, and improvements were noted in macronutrient balance and clinical parameters (blood pressure, body mass index, waist circumference, glycemic values) [41]. A literature review by Ekong and Kavookjian (2016) also reported that MI-based interventions were effective in improving weight control and dietary behaviors in individuals with type 2 DM [42]. Furthermore, the literature indicates that MI significantly contributes to the development of healthy eating behaviors in pregnant women and to achieving recommended gestational weight gain [43]. However, conflicting findings have also been reported regarding the effects of motivational interviewing on dietary behaviors. In a randomized controlled trial conducted by Jansink et al. among individuals with type 2 diabetes, lifestyle counselling based on motivational interviewing principles did not result in significant improvements in dietary behaviors or physical activity compared with usual care [44]. These differences may be related to variations in the study population, intervention duration, and participants’ readiness for behavior change. The positive findings observed in the present study may be explained by the unique context of GDM, where concerns regarding maternal and fetal health may enhance motivation to adopt healthier lifestyle behaviors. Overall, consistent with much of the existing literature, the findings of this study demonstrate that MI is an effective approach for improving nutritional behaviors among pregnant women diagnosed with GDM. This study also found that MI was effective in increasing pregnant women’s self-efficacy in managing their health. The significant increase in self-efficacy scores in the intervention group after the intervention and at follow-up, along with the large effect size for the group x time interaction (η2p = 0.435), indicates that MI strongly supports individuals’ capacity to initiate, maintain, and manage health behaviors [35]. No significant change was observed in the control group over time. These findings are consistent with the literature. Selçuk Tosun and Zincir (2016) reported that MI based on the transtheoretical model significantly increased self-efficacy levels in individuals with type 2 DM [45]. Similarly, an eight-session tele-nursing-based MI intervention was shown to improve self-efficacy in individuals with type 2 DM [46]. Another study reported that five sessions of MI in addition to standard care significantly increased self-efficacy scores in individuals with type 2 DM [47]. Moreover, a systematic review examining MI-based telehealth interventions in individuals diagnosed with DM and prediabetes evaluated the results of 21 randomized controlled trials and concluded that MI-based telehealth applications were among the most effective methods for improving self-efficacy [48]. However, a study examining the effects of motivational interviewing on self-efficacy among individuals with diabetes reported that although short-term improvements in self-efficacy were observed following the intervention, these differences were not maintained during long-term follow-up [49]. This finding suggests that the effectiveness of motivational interviewing may vary depending on sample characteristics, baseline motivation, intervention duration, and follow-up period. In the present study, the more pronounced effect on self-efficacy may be explained by the unique context of GDM, where concerns regarding maternal and fetal health may increase awareness and strengthen motivation for behavior change during pregnancy. Accordingly, the findings of the present study suggest that MI may produce strong and positive effects on self-efficacy not only in diabetes management but also among pregnant women diagnosed with GDM. This study expands the existing literature by demonstrating the effectiveness of MI in enhancing self-efficacy in women with GDM. In this study, the effectiveness of MI was evaluated through the subdimension scores of the SF-36. Although no significant differences were observed between groups at baseline, after MI and at the 4-week follow-up, the intervention group demonstrated significantly higher scores in physical functioning, role limitations due to emotional problems, energy, mental health, social functioning, and general health perception compared to the control group. These findings indicate that MI is an effective and feasible method for improving quality of life in pregnant women diagnosed with GDM. Quality of life is a multidimensional concept that reflects an individual’s perception of their life conditions in relation to their values, expectations, goals, and cultural context [48]. Since GDM imposes additional physiological and psychological burdens during pregnancy and poses risks for both mother and fetus, monitoring and supporting quality of life in pregnant women is essential [51–53]. Previous studies have reported that women diagnosed with GDM have lower quality of life compared to women with normal pregnancies [14, 15]. Systematic review and meta-analysis findings indicate that GDM may negatively affect quality of life, particularly in mental and social health dimensions [54]. Another study demonstrated that quality of life in pregnant women with GDM is influenced by concerns related to high-risk pregnancy [55]. In the present study, significant increases were observed in several SF-36 subdimensions among pregnant women who received MI, including physical functioning (η2p = 0.106), role limitations due to emotional problems (η2p = 0.048), energy (η2p = 0.249), mental health (η2p = 0.284), social functioning (η2p = 0.152), and general health perception (η2p = 0.409), with effect sizes ranging from moderate to large [35]. No statistically significant changes were observed in the role limitations due to physical problems and pain subdimensions. In a study by Kılıç Barmanpek, MI strengthened with game-based mobile technology increased quality of life in patients with type 2 DM [56]. Similarly, Seki Öz and Büyüksoy (2022) reported that MI improved quality of life by enhancing healthy lifestyle behaviors [57]. Systematic reviews have generally demonstrated that MI improves quality of life in individuals with chronic diseases [59–61]. These findings are consistent with the results of the present study. However, some studies have reported that MI does not have a significant effect on quality of life [44, 62]. Jansink et al. demonstrated that a comprehensive diabetes care program integrating motivational interviewing into routine care failed to improve quality of life among individuals with type 2 diabetes. Similarly, Uzun and Özmaya reported no significant differences in quality-of-life outcomes following motivational interviewing interventions [62]. These inconsistent findings may be attributed to differences in study populations, intervention content, duration and intensity of the intervention, as well as participants’ readiness for behavior change. In the present study, the more pronounced effects of MI on quality of life may be explained by the fact that pregnant women diagnosed with GDM may be more receptive to behavior change due to concerns regarding maternal and fetal health. Furthermore, the temporary and pregnancy-specific nature of GDM may increase motivation to engage in health-promoting behaviors, thereby enhancing the effectiveness of MI. Therefore, the positive effects observed on multiple dimensions of quality of life suggest that motivational interviewing may be a particularly valuable intervention for supporting women facing the challenges of GDM during pregnancy. Overall, the current findings support the effectiveness of MI in improving quality of life during pregnancy. Limitations This study has several limitations. Since the research was conducted within a single sample group, the generalizability of the findings is limited. Due to the nature of the intervention, blinding could not be implemented, which may have increased the risk of measurement and performance bias. Because post-test and follow-up measurements of participants who withdrew from the study were missing, missing data could not be reliably estimated; therefore, intention-to-treat analysis could not be performed, and analyses were conducted using a per-protocol approach. The collection of data based on self-report may have led to social desirability and recall bias. In addition, limiting the MI sessions to four sessions and the short follow-up period restricted the evaluation of the long-term effects of the intervention. Accordingly, further studies are needed with larger and more diverse samples, longer follow-up periods, and, when possible, supported by objective measurements (e.g., clinical indicators/device-based activity monitoring). Conclusions and recommendations The findings of this study demonstrate that MI significantly and positively increased self-efficacy in managing health and quality of life among pregnant women diagnosed with GDM. These results indicate that MI is an effective and feasible counseling approach in the management of GDM. It is recommended that the MI approach be disseminated in clinical practice and midwifery education programs. Furthermore, its effectiveness should be supported through studies conducted with larger sample groups, longer follow-up periods, and in different centers. Supplementary Information Supplementary Material 1. Supplementary Material 1.